ES2058173T3 - Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion. - Google Patents

Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.

Info

Publication number
ES2058173T3
ES2058173T3 ES88107382T ES88107382T ES2058173T3 ES 2058173 T3 ES2058173 T3 ES 2058173T3 ES 88107382 T ES88107382 T ES 88107382T ES 88107382 T ES88107382 T ES 88107382T ES 2058173 T3 ES2058173 T3 ES 2058173T3
Authority
ES
Spain
Prior art keywords
manufacture
dioxialquilenaril
dihidropiridinas
procedures
intermediate products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88107382T
Other languages
English (en)
Inventor
Gerhard Dr Franckowiak
Albrecht Dr Marhold
Martin Dr Bechem
Rainer Prof Dr Gross
Michael Dr Kayser
Matthias Dr Schramm
Gunther Dr Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2058173T3 publication Critical patent/ES2058173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVAS DIOXIALQUILENARILDIHIDROPIRIDINAS DE FORMULA GENERAL (I) DONDE R1 A R6 TIENEN EL SIGNIFICADO QUE SE INDICA EN LA DESCRIPCION, PRODUCTOS INTERMEDIOS PARA SU OBTENCION Y SU APLICACION EN MEDICAMENTOS, EN PARTICULAR MEDICAMENTOS QUE ACTUAN SOBRE LA CIRCULACION.
ES88107382T 1987-05-19 1988-05-07 Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion. Expired - Lifetime ES2058173T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873716652 DE3716652A1 (de) 1987-05-19 1987-05-19 Dioxyalkylenaryl-dihydropyridine, zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ES2058173T3 true ES2058173T3 (es) 1994-11-01

Family

ID=6327815

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88107382T Expired - Lifetime ES2058173T3 (es) 1987-05-19 1988-05-07 Dioxialquilenaril-dihidropiridinas, productos intermedios para su fabricacion, procedimientos para su fabricacion y su utilizacion.

Country Status (6)

Country Link
US (2) US4886816A (es)
EP (1) EP0291799B1 (es)
JP (2) JP2558326B2 (es)
AT (1) ATE90676T1 (es)
DE (2) DE3716652A1 (es)
ES (1) ES2058173T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194628A (en) * 1988-03-18 1993-03-16 Ciba-Geigy Corporation Process for the preparation of substituted difluorobenzo-1,3-dioxoles
US5420301A (en) * 1988-03-18 1995-05-30 Ciba-Geigy Corporation Process for the preparation of substituted difluorobenzo-1,3-dioxoles
CH687877A5 (de) * 1988-03-18 1997-03-14 Ciba Geigy Ag 2,2-Difluorbenzo-1,3-dioxol-4-carbaldehyd.
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
DE4133155A1 (de) * 1991-10-07 1993-04-08 Bayer Ag Verfahren zur herstellung von 2,2-difluorbenzo (1,3)-dioxol-carbaldehyden und neuen zwischenprodukten
DE4133156A1 (de) * 1991-10-07 1993-04-08 Bayer Ag Verfahren zur herstellung von fluorsubstituierten aminobenzodioxolen und -benzodioxanen und neue zwischenprodukte
DE4133157A1 (de) * 1991-10-07 1993-04-08 Bayer Ag In 4-stellung substituierte derivate von 2,2-dihalogenbenzo (1,3) dioxolen, verfahren zu ihrer herstellung ung ihrer verwendung
US7765039B1 (en) * 1994-02-15 2010-07-27 Hagenbuch Leroy G Apparatus for tracking and recording vital signs and task-related information of a vehicle to identify operating patterns
US5633218A (en) * 1995-05-24 1997-05-27 E. I. Du Pont De Nemours And Company Herbicidal benzodioxoles and benzodioxanes
EP0854721B1 (en) * 1995-08-02 2001-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
DE19530637A1 (de) * 1995-08-21 1997-02-27 Bayer Ag Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE19731785A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von 2,2,3,3-Tetrafluor-1,4-benzodioxanen, neue o-(2-Brom-1,1,2,2-tetrafluorethoxy)-phenole und neue 2-Brom-1,1,2,2-tetrafluorethoxy-gruppen enthaltende Phenylether
DE19929783A1 (de) * 1999-06-29 2001-01-04 Bayer Ag Substituierte 6-[4-(Oxymethyl)-phenyl]-dihydropyridazinone und ihre Verwendung
CA2501534A1 (en) * 2002-10-07 2004-04-22 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
CN101851225B (zh) * 2010-06-09 2012-08-08 山东铂源化学有限公司 一种咯菌腈中间体4-醛基-2,2-二氟苯并二恶茂的合成方法
CN106749156B (zh) * 2016-12-02 2020-04-10 浙江永宁药业股份有限公司 苯并[1,3-d]间二氧杂环戊烯及其中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819788A1 (de) * 1978-05-05 1979-11-08 Bayer Ag Benzylester mit fluorsubstituierten aether- und/oder thioaethergruppen und ihre verwendung als insektizide
DE2916358A1 (de) * 1979-04-23 1980-11-06 Bayer Ag Substituierte styrylcyclopropancarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide und akarizide
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3478685D1 (en) * 1983-03-04 1989-07-20 Nikken Chemicals Co Ltd 1,4-dihydropyridine compound
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
US4567268A (en) * 1984-04-03 1986-01-28 Merck & Co., Inc. Process for preparation of certain tetrahydrofuro[3,4-b]pyridines
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd １，４−ジヒドロピリジン誘導体
US4705800A (en) * 1985-06-21 1987-11-10 Ciba-Geigy Corporation Difluorbenzodioxyl cyanopyrrole microbicidal compositions

Also Published As

Publication number Publication date
DE3881759D1 (de) 1993-07-22
US4886816A (en) 1989-12-12
EP0291799A3 (en) 1989-12-20
JP2721822B2 (ja) 1998-03-04
JPS63303980A (ja) 1988-12-12
JP2558326B2 (ja) 1996-11-27
EP0291799B1 (de) 1993-06-16
EP0291799A2 (de) 1988-11-23
DE3716652A1 (de) 1988-12-08
ATE90676T1 (de) 1993-07-15
US5344944A (en) 1994-09-06
JPH08245613A (ja) 1996-09-24

Similar Documents

Publication Publication Date Title
EP0291799A3 (en) Dioxyalkylenearyl-dihydropyridines and their intermediary compounds, process for their preparation and their use
NO914091D0 (no) Fremgangsmaate for fremstilling av hydroksylerte inhibitorer for hiv-reverstranskriptase
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
SE8404019D0 (sv) Oftalmiskt medel
SE8900039D0 (sv) Isoquinoline derivatives their preparation and their use
SE8600413D0 (sv) Nytt lekemedel och sett att framstella detsamma
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
ES480299A1 (es) Procedimiento de preparacion de nuevos acidos alfa-(hidroxi-alcohil)-lactama-n-aceticos y de sus amidas.
DK96286A (da) 6-amidino-2-naphthyl-4-amino-benzoat-derivater og farmaceutisk acceptable syreadditionssalte deraf
DK323179A (da) Polyalkoxyphenylpyrrolidoner iii, fremgangsmaade til deres femstilling og deres anvendelse
DK67384A (da) N-iminopyridiniumbetainderivater
SE8100846L (sv) Antirinovirusmedel
FR2327995A1 (fr) Procede ameliore de preparation de vanadate d'ethyle
ATE32715T1 (de) Verfahren zur herstellung von b-((2methylpropoxy)-methyl>-n-phenyl-n-(phenylmethyl - 1-pyrrolidinethanamin.
ES2149247T3 (es) Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
FI925618A0 (fi) Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar
DE69232406D1 (de) Verfahren zur Herstellung von Fluoro-Chinolin-3-Carbonsäurederivate
ES2067417B1 (es) Procedimiento para preparar nuevos derivados en n de (feniletil-beta-ol)-amina.
SE8804255D0 (sv) Framstaellning av alkanolaminderivat
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
SE7712447L (sv) Sett att framstella nya bensofenonderivat
ATE17729T1 (de) Neue cephalosporinderivate, verfahren zu ihrer herstellung und zwischenprodukte dafuer sowie entsprechende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 291799

Country of ref document: ES